ChiefBrief Daily Podcast
Sepsis remains the leading cause of in-hospital mortality, but the strategic landscape for CMOs is shifting rapidly in 2026 with the first FDA 510(k) clearance of a continuous AI sepsis monitoring system and emerging evidence that age-stratified treatment approaches may outperform one-size-fits-all bundle protocols. CMOs must now reconcile bundle compliance discipline with a new generation of predictive tools, novel biomarker panels, and biology-informed care pathways that challenge longstanding assumptions about uniform sepsis management.
43 episodes
Comments
0Be the first to comment
Sign up now and become a member of the ChiefBrief Daily Podcast community!